Individual #00327400

ID_report M73 II-1
Reference Doucette 2021, submitted
Remarks single child to unaffected parents (father was unavailable for examination)
Gender M
Consanguinity yes
Country Canada
Population Middle Eastern
Age at death -
VIP -
Data_av Yes
Treatment -
Panel size 1
Diseases DFNB, maculopathy
Owner name Lance P Doucette
Database submission license No license selected
Created by Lance P Doucette
Date created 2021-01-20 21:53:20 +01:00 (CET)
Date last edited 2021-01-21 13:53:02 +01:00 (CET)


Phenotypes

maculopathy (maculopathy)   Add phenotype for this disease

AscendingPhenotype ID     

Diagnosis/Initial     

Diagnosis/Definite     

Phenotype details     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000245691 - - Fundus/History: Bilateral macular schisis, vitreous veils, mild pigmentary retinopathy. Right eye developed shallow rhegmatogenous inferior retinal detachment, and was treated by scleral buckle procedure, cryotherapy with gas injection. Ocular Coherence Tomography: Bilateral parafoveal thinning of the outer retina layers. Central splitting between the inner nuclear and the outer plexiform layer. Electroretinogram (ERG): Small residual cone flicker (6.2 microV in OD, and 7.1 microV in OS) with no measurable responses to ISCE standard seriesd ERG in ffERG Familial, autosomal recessive 11y - - - - Lance P Doucette



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000328612 DNA SEQ-NG - - - 4 Lance P Doucette



Variants

4 entries on 1 page. Showing entries 1 - 4.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
6 Paternal (confirmed) +/. - pathogenic (recessive) g.42935188C>T - - - PEX6_000006 This variant was noted as heterozygous in this patient. The variant is previously associated with Heimler syndrome, a peroxisomal biogenesis disorder. Possible explanation for this patient, however a second variant in PEX6 is yet to be identified. Doucette 2021, submitted ClinVar-198709 rs34324426 Germline yes - - - - Lance P Doucette PEX6 - - - - - NM_000287.3:c.1802G>A - r.(?) p.(Arg601Gln) - - - - - - - - - - - - - -
10 Unknown ?/. - VUS g.73337684G>A - - - CDH23_000476 Was noted as heterozygous in this patient. As CDH23 can cause non-syndromic hearing loss, we took interest in variations in this gene due to the hearing loss noted in the patient. Doucette 2021, submitted ClinVar-752696 rs371646164 Germline - 5.40E-04 - - - Lance P Doucette CDH23 - - - - - NM_022124.5:c.767G>A - r.(?) p.(Arg256His) - - - - - - - - - - - - - -
10 Both (homozygous) ?/. - likely benign g.73453990C>T g.71694233C>T - - CDH23_000111 - Doucette 2021, submitted ClinVar-45891 rs181255269 Germline yes - - - - Lance P Doucette CDH23 - - - - - NM_022124.5:c.2263C>T - r.(?) p.(His755Tyr) - - - - - - - - - - - - - -
10 Both (homozygous) ?/. - VUS g.73560445T>A g.71800688T>A - - CDH23_000855 likelynovel variant Doucette 2021, submitted - - Germline yes - - - - Lance P Doucette CDH23 - - - - - NM_022124.5:c.7415T>A - r.(?) p.(Ile2472Asn) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.